Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab
Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Purpose Real-world data and study data regarding therapy with Emicizumab in pediatric cohorts with haemophilia A is scarce. Especially, data on previously untreated pediatric patients (PUPs) and minimally treated patients (MTPs) are missing. Methods Thirteen pediatric patients with haemophilia A and treatment with Emicizumab were retrospectively ev...
Alternative Titles
Full title
Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b896cb4666e64456bb429e4b9008408d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b896cb4666e64456bb429e4b9008408d
Other Identifiers
ISSN
1471-2431
E-ISSN
1471-2431
DOI
10.1186/s12887-022-03546-1
